Hong Kong stocks soar | Sansheng Pharmaceuticals (01530.HK) up nearly 5% again, institutions say Pfizer's 707 global clinical trial progress exceeds market expectations.

According to the Wise Finance and Economics APP, Sansei Pharmaceuticals (01530.HK) rose by nearly 5% again, as of the time of publication, up 4.03% to HK$35.14, with a transaction value of HK$1.129 billion.